Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2012
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308641 Compositions and Methods for Enhancing Coagulation Factor VIII Function
12/06/2012US20120308639 Mesocellular Oxide Foams as Hemostatic Compositions and Methods of Use
12/06/2012US20120308638 Antimicrobial peptides
12/06/2012US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery
12/06/2012US20120308613 Formulations for use in inhaler devices
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012US20120308583 Use of gcc ligands
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308567 Use of tyrosine kinase inhibitors for treatment of prolactinoma
12/06/2012US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012US20120308553 Oral medication for the treatment of hemorrhoids and method of use
12/06/2012US20120308552 Hemostatic bio-material composition and method
12/06/2012US20120308551 Protease screening methods and proteases identified thereby
12/06/2012US20120308550 Method of Using Fish Plasma Components to Promote Functional Recovery in the Mammialian CNS
12/06/2012US20120308549 Process for production and purification of recombinant lysosomal alpha-mannosidase
12/06/2012US20120308548 Methionine gamma lyase-2-aminobutyrate deaminase (megl-2abd) and therapeutic uses thereof
12/06/2012US20120308547 Compositions and methods of using chondroitinase abci mutants
12/06/2012US20120308546 Polymers for reversing heparin-based anticoagulation
12/06/2012US20120308545 Crystallized Oxalate Decarboxylase and Methods of Use
12/06/2012US20120308544 Substances and Methods for the Treatment of Lysosmal Storage Diseases
12/06/2012US20120308543 Lipase Variants for Pharmaceutical Use
12/06/2012US20120308541 Pharmaceutical composition for treating the gastrointestinal tract
12/06/2012US20120308540 Modified factor IX polypeptides and uses thereof
12/06/2012US20120308538 Preventing spoilage in alcohol fermentations
12/06/2012US20120308532 Composition for the treatment of a bone fracture
12/06/2012US20120308526 Sonic Low Pressure Spray Drying
12/06/2012US20120308525 Nutritional compositions including a high protein component and exogenous nucleotides
12/06/2012US20120308524 Composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency
12/06/2012US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
12/06/2012US20120308519 Anti-Arenaviral Compounds
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308517 Compositions for the treatment of infectious and tumoural diseases
12/06/2012US20120308516 Use of metallocene compounds for cancer treatment
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012US20120308514 Human antibodies that bind human il-12 and methods for producing
12/06/2012US20120308513 Promiscuous her-2/neu cd4 t cell epitopes
12/06/2012CA2874998A1 Methods, compositions, and kits for the treatment of cancer
12/06/2012CA2837858A1 Blockade of inflammatory proteases with theta - defensins
12/06/2012CA2837856A1 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
12/06/2012CA2837851A1 Non-peptidyl polymer-insulin multimer and method for producing the same
12/06/2012CA2837710A1 Long-acting glp-1/glucagon receptor agonists
12/06/2012CA2837412A1 Dispersion and detachment of cell aggregates
12/06/2012CA2836946A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012CA2836478A1 Therapeutic proteins with increased half-life and methods of preparing same
12/06/2012CA2835859A1 Extracellular matrix material conduits and methods of making and using same
12/06/2012CA2834832A1 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/05/2012EP2530156A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530155A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530154A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530153A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2529755A1 Pharmaceutical composition and preparation for oral administration
12/05/2012EP2529746A1 Methods for treatment or prophylaxis of reperfusion injury
12/05/2012EP2529745A1 VEGF-D/VEGFR mediated regulation of dendrites
12/05/2012EP2529619A2 Treating neurological disorders
12/05/2012EP2528941A2 Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery
12/05/2012EP2528938A2 Pro-angiogenic fragments of prominin-1 and uses thereof
12/05/2012EP2528937A1 Modified melk peptides and vaccines containing the same
12/05/2012EP2528936A1 Cyclic peptides binding cxcr4 receptor and relative medical and diagnostic uses
12/05/2012EP2528934A1 Aromatic-cationic peptides and uses of same
12/05/2012EP2528895A2 Trypsin-like serine protease inhibitors, and their preparation and use
12/05/2012EP2528619A1 Screening method for identifying compounds which block tumour growth by inducing irreversible senescence in tumour cells
12/05/2012EP2528618A1 Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
12/05/2012EP2528617A1 Cytokines for the treatment of addictions
12/05/2012EP2528616A1 Neuregulin based compositions and uses thereof for preventing, treating or delaying the myocardial ischemia-reperfusion injury
12/05/2012EP2528615A1 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
12/05/2012EP2528614A1 Methods of treating glucose metabolism disorders
12/05/2012EP2528613A1 Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates
12/05/2012EP2528612A1 Methods of treating glucose metabolism disorders
12/05/2012EP2528611A1 A composition for use in the therapy of lactose intolerance or conditions arising from lactase deficiency
12/05/2012EP2528456A1 Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
12/05/2012CN1437479B Recombinant intracellular pathogen vaccines and methods for use
12/05/2012CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same
12/05/2012CN102811763A Proteoglycan-containing microneedle array
12/05/2012CN102811744A Chemically Modified Cell-penetrating Peptides For Improved Delivery Of Gene Modulating Compounds
12/05/2012CN102811731A Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
12/05/2012CN102811730A Methods for the use of progestogen as a glucocorticoid sensitizer
12/05/2012CN102811729A Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol
12/05/2012CN102811717A Nutritional composition
12/05/2012CN102811704A Method of use of stabilized plant-derived growth factor in skin care
12/05/2012CN102808016A Applications of ARID1A gene and protein product encoded by the same
12/05/2012CN102807987A Meretrix intracellular copper zinc superoxide dismutase gene and application thereof
12/05/2012CN102807973A A variant form of urate oxidase and use thereof
12/05/2012CN102807619A Compound containing immunoglobulin Fc segment and granulocyte macrophage-colony stimulating factor and pharmaceutical compositions of compound
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102807612A Polypeptide fragment and preparation method and application thereof
12/05/2012CN102807610A Antibacterial peptides and application of antibacterial peptides to preparation of medicament resisting drug-resistant bacteria
12/05/2012CN102807609A Polypeptide for preventing and/or treating pain and application of polypeptide
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102807607A Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
12/05/2012CN102807606A Oligopeptide with antitumor and antiadhesion activities and synthesis method and application thereof
12/05/2012CN102807605A Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof
12/05/2012CN102807604A N alpha-(1,3-dioxy-4,4,5,5-tetramethyl imidazoline-2-phenyl-4'-oxo acetyl)-N omega-fatty acyl-Lys-Arg-Gly-Asp-Val and preparation method and application thereof
12/05/2012CN102807603A Aliphatic amine chain modified anti-tumor oligopeptide and synthetic method and application thereof
12/05/2012CN102807602A Peptide and composition thereof for improving liver dysfunction
12/05/2012CN102807601A Aminoacyl-tryptophanyl-5-methoxytryptamine and preparation method and application thereof
12/05/2012CN102807600A Amino acid modified spinacin derivative and preparation method and application thereof
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 3163